Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 35:112-118
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoffmeister, A.
Right arrow Articles by Koenig, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffmeister, A.
Right arrow Articles by Koenig, W.

Seropositivity to chlamydial lipopolysaccharide and chlamydia pneumoniae, systemic inflammation and stable coronary artery disease

Negative results of a case-control study

Albrecht Hoffmeister, MD*, Dietrich Rothenbacher, MD, MPH{dagger}, Peter Wanner, MS*, Guenter Bode, PhD§, Kenneth Persson, MD, PhD{ddagger}, Hermann Brenner, MD, MPH{dagger}, Vinzenz Hombach, MD* and Wolfgang Koenig, MD, FACC*

* Department of Internal Medicine II–Cardiology, University of Ulm, Ulm, Germany
{dagger} Department of Epidemiology, University of Ulm, Ulm, Germany
{ddagger} Department of Clinical Microbiology, Malmö General Hospital, University of Lund, Malmö, Sweden
§ Department of Internal Medicine I–Gastroenterology, University of Ulm, Ulm, Germany



View larger version (14K):

[in a new window]
 
Figure 1 Distribution of the prevalence of IgG antibodies against Chlamydia pneumoniae by different titres based on microimmunofluorescence (MIF) in cases and controls (n = 791).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement